PPT-Trends in opioid a buse:

Prescription opioid abuse and the resurgence of heroin Statewide Public Health System Meeting July 27 2017 Dr Theodore J Cicero PhD Washington University in St Louis Department of Psychiatry. Kenneth L. Kirsh. , . Ph.D.. Clinical Research Educator and Research Scientist. Millennium . Laboratories. Millennium Research Institute. San Diego, CA. The Opioid Pendulum. Opiophobia. Balance of Addiction Medicine and Pain Management Principles. David Kan, M.D.. University of California. San Francisco. VA Medical Center. San Francisco. History of Opioids. The “Pod of Pleasure”. OTC Opiates. Opium. Smoker. Opium in San Francisco. Gentlemen prefer…opium. Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None.      Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill.  He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship.  While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972.  For this he receive the  Meritorious Service Medal.  He has practiced adult psychiatry in Grand Junction for 28 years.  He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Training of Trainers. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Agenda. Massachusetts Department of Public Health. Bureau of Substance Abuse Services. Understanding Opioids. How it Happened. . Andrew Kolodny, M.D.. .. Executive Director, Physicians for Responsible Opioid Prescribing. Co-Director, Opioid Policy Research Collaborative, . Heller School for Social Policy and Management, Brandeis University. Naloxone Education for Virginia. . . Training of Trainers Presentation. . . Revised May 16, 2017. REVIVE!. – Responding to an Opioid Overdose Emergency. Welcome and Introductions. Please sign in. Prescription opioid abuse and the resurgence of heroin. Opioid Crisis Summit Meeting. October 17, . 2017. Dr. Theodore J. Cicero, PhD. Washington University in St. Louis,. Department of Psychiatry. Email: . John e lopes . j. r. .. , . dhs. c. , pa-c. A. ssociate Professor, . Physician Assistant Program. Central Michigan University. and . Project Director. Medication-assisted Treatment Waiver Training Initiative. IN ARMS September 26, 2016. Prepared by. Leslie . Hulvershorn. , MD. Medical Director,. . Division of Mental Health and . Addiction, FSSA. Leslie.Hulvershorn@fssa.IN.gov. Presented by. Dennis Ailes, MA. Analgesics and Opioids. Analgesics are drugs that relieve pain without causing loss of consciousness.. Opioids are the . most effective pain relievers available.. Terminology. Opioid. . A general term defined as any drug, natural or synthetic, that . Section I: welcome and introductions. 2. Name Tent. 3. Years of service. Experience with families experiencing opioid use or addiction?. Personal goal for this training. NAME. County. . Learning Objectives:. Mental Health Roundtable. October 6, 2017. Last year, 1138 . Virginians died . from . an opioid overdose. . Profile of Opioid Addiction. Opioids are natural and synthetic compounds that bind to the brain’s opioid receptors and trigger the release of dopamine. . Welcome. Thank you for joining us for our 1. st. AIM Opioid Webinar. Housekeeping:. Session is being recorded. Session will be posted under the opioid section of the AIM website: . https://safehealthcareforeverywoman.org/national-collaborative-on-maternal-oud/. Katherine Wang, . Pharm.D. .. The Center for Children and Women – . Greenspoint. Conflict of Interest Disclosure. The presenters, planners, reviewers (including CME administrator) of today’s CME activity do not have any financial relationships or commercial interests to disclose.